XENOPORT, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 72183
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 4890
 
  
 
C07D HETEROCYCLIC COMPOUNDS 20142
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 887
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 742
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2123
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204
 
  
 
A61J CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 129
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 169

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0183,296 CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOGMar 13, 17Jun 29, 17[C07C]
2017/0157,056 ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOFJan 07, 16Jun 08, 17[A61K]
2017/0035,714 Oral Dosage forms having a High Loading of a Gabapentin ProdrugOct 14, 16Feb 09, 17[A61K]
2015/0307,914 METHODS OF ADMINISTERING MONOMETHYL FUMARATE AND PRODRUGS THEREOF HAVING REDUCED SIDE EFFECTSAug 01, 14Oct 29, 15[A61K, C12Q]
2015/0252,013 TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATEMay 20, 15Sep 10, 15[C07D, C07C]
2015/0190,360 METHODS OF ADMINISTERING MONOMETHYL FUMARATEMar 18, 15Jul 09, 15[A61K]
2014/0348,915 Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs ThereofAug 22, 13Nov 27, 14[A61K]
2014/0350,018 Methods of Administering Monomethyl Fumarate and Prodrugs Thereof Having Reduced Side EffectsAug 22, 13Nov 27, 14[A61K]
2014/0056,973 Oral Dosage Forms Having a High Loading of a Methyl Hydrogen Fumarate ProdrugAug 22, 13Feb 27, 14[A61K]
2013/0324,539 Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen FumarateMay 30, 13Dec 05, 13[A61K, C07D, C07C]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9895336 Crystalline forms of (N, N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and useSep 06, 17Feb 20, 18[A61K, C07C]
9795581 Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and useMay 08, 17Oct 24, 17[A61K, C07C]
9682057 Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and useJul 20, 16Jun 20, 17[A61K, C07C]
9597292 Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofAug 22, 13Mar 21, 17[A61K]
9533941 Methods of synthesizing a levodopa ester prodrugFeb 12, 16Jan 03, 17[C07C]
9452972 Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereofJun 06, 14Sep 27, 16[C07D, C07C]
9421182 Cocrystals of dimethyl fumarateJun 20, 14Aug 23, 16[A61K, C07C]
9416096 Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and useSep 05, 14Aug 16, 16[C07C]
9353057 Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereofJan 15, 13May 31, 16[C07D, C07C]
9302977 Method of making monomethyl fumarateJun 06, 14Apr 05, 16[C07D, C07C]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0090,353 PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOFAbandonedDec 08, 15Mar 31, 16[C07C]
2015/0353,483 CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOGAbandonedAug 20, 15Dec 10, 15[C07C]
2015/0158,809 METHOD OF MAKING 1-(ACYLOXY)-ALKYL CARBAMATE COMPOUNDSAbandonedFeb 25, 14Jun 11, 15[C07C]
2015/0157,590 COCRYSTALS OF (N,N-DIETHYLCARBAMOYL)METHYL METHYL (2E)BUT-2-ENE-1,4-DIOATEAbandonedNov 05, 13Jun 11, 15[A61K]
2015/0079,180 NANOPARTICLE COMPOSITIONS OF DIMETHYL FUMARATEAbandonedSep 18, 14Mar 19, 15[A61K]
2015/0072,004 GABA ANALOG PRODRUG SUSTAINED RELEASE ORAL DOSAGE FORMSAbandonedNov 04, 14Mar 12, 15[A61K]
2014/0275,250 Methods of Administering Monomethyl FumarateAbandonedAug 22, 13Sep 18, 14[A61K]
2014/0057,918 Methods of Use for Monomethyl Fumarate and Prodrugs ThereofAbandonedAug 22, 13Feb 27, 14[C07D, C07C]
2014/0051,705 Morpholinoalkyl Fumarate Compounds, Pharmaceutical Compositions, and Methods of UseAbandonedAug 14, 13Feb 20, 14[C07D]
2013/0102,641 PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOFAbandonedDec 13, 12Apr 25, 13[C07C]
2012/0296,109 Levodopa Prodrugs, and Compositions and Uses ThereofAbandonedMay 16, 12Nov 22, 12[C07C]
2012/0190,861 Levodopa Prodrugs, and Compositions and Uses ThereofAbandonedApr 05, 12Jul 26, 12[C07D, C07C]
8202852 Creatine phosphate analog prodrugs, compositions and uses thereofExpiredFeb 03, 10Jun 19, 12[A61K, C07F]
8168617 Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of useExpiredSep 05, 08May 01, 12[A61K, C07F, C07C]
2012/0082,645 2'-C-METHYL-RIBOFURANOSYL CYTIDINE PRODRUGS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOFAbandonedNov 04, 11Apr 05, 12[A61K, A61P]
2012/0041,061 USE OF PRODRUGS OF GABA ANALOGS FOR TREATING DISEASESAbandonedOct 27, 11Feb 16, 12[A61K, A61P]
2012/0016,021 METHODS OF TREATING FRAGILE X SYNDROME, DOWN'S SYNDROME, AUTISM AND RELATED DISORDERSAbandonedJul 15, 11Jan 19, 12[A61K]
2011/0294,879 METHOD OF TREATMENT OF FRAGILE X SYNDROME, DOWN'S SYNDROME, AUTISM AND RELATED DISORDERSAbandonedMay 27, 11Dec 01, 11[A61K, A61P]
8067455 Amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereofExpiredOct 02, 09Nov 29, 11[A61K]
8058260 2′-C-methyl-ribofuranosyl cytidine prodrugs, pharmaceutical compositions and uses thereofExpiredMay 22, 07Nov 15, 11[A61K, C07H]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.